戻る
Shandong Boan Biotechnology Co., Ltd. (06955.HK)価格
06955.HK 株価推移チャート
BOAN BIOTECH (06955.HK)
Shandong Boan Biotechnology Co., Ltd.
HK$9.02
-0.66%
$-0.06
レギュラーマーケット： Jan 20, 11:42:26 HKT
データなしEarnings FAQ
06955.HKの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Shandong Boan Biotechnology Co., Ltd. 06955.HKの前四半期の収益はどうでしたか？
Shandong Boan Biotechnology Co., Ltd.の収益見積もりはいくらですか？
Shandong Boan Biotechnology Co., Ltd.の収益品質スコアはどれくらいですか？
Shandong Boan Biotechnology Co., Ltd.はいつ収益を報告しますか？
Shandong Boan Biotechnology Co., Ltd.の予想収益はいくらですか？
Shandong Boan Biotechnology Co., Ltd.は収益予想を上回りましたか？
主要データ
前終値
$9.04
始値
$9.08
当日レンジ
$8.96 - $9.2
52週レンジ
$7.71 - $25
取引高
865.0K
平均取引高
4.3M
1株当たり利益(TTM)
0.07
配当利回り
--
時価総額
$5.6B
BOAN BIOTECHとは何ですか？
Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company, which engages in therapeutic antibody development, manufacturing and commercialization. The company is headquartered in Yantai, Shandong and currently employs 714 full-time employees. The company went IPO on 2022-12-30. The firm is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The firm has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The firm operates mainly in the domestic Chinese market and overseas markets.